Skip to main content
Harbin Pharmaceutical Group Co.,Ltd. logo

Harbin Pharmaceutical Group Co.,Ltd. — Investor Relations & Filings

Ticker · 600664 ISIN · CNE0000009T3 LEI · 300300G0L086UJ23MI26 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,827 across all filing types
Latest filing 2017-10-25 Declaration of Voting R…
Country CN China
Listing Shanghai Stock Exchange 600664

About Harbin Pharmaceutical Group Co.,Ltd.

https://www.hayao.com/

Harbin Pharmaceutical Group Co., Ltd. specializes in the research, development, manufacture, and distribution of a diverse range of pharmaceutical and healthcare products. The company's portfolio includes antibiotics, over-the-counter (OTC) medicines, health supplements, traditional Chinese medicines, and animal health products. It operates through several specialized subsidiaries and maintains a significant presence in the production of penicillins and cephalosporins. A key strategic focus involves the health and nutrition sector, bolstered by the acquisition of global nutrition brand GNC. The company leverages large-scale manufacturing capabilities and an extensive distribution network to serve both domestic and international markets. Its operations emphasize technological innovation and quality control across its integrated supply chain, from raw material production to finished dosage forms.

Recent filings

Filing Released Lang Actions
2017年第二次临时股东大会之法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the 2017 second extraordinary general meeting (临时股东大会) of Harbin Pharmaceutical Group Co., Ltd. It details the legality of the meeting's convening, attendance, voting procedures, and results. The document focuses on the validation of the shareholder meeting process and the voting outcomes for board and supervisory committee nominations. It does not contain financial statements or financial performance data. It is not an announcement of a report but a legal opinion on the shareholder meeting and its resolutions. This type of document corresponds to a Declaration of Voting Results & Voting Rights Announcements (DVA), as it officially reports the voting results of a shareholder meeting.
2017-10-25 Chinese
2017年第二次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled as a resolution announcement from a 2017 second extraordinary shareholders' meeting (临时股东大会决议公告). It details the meeting date, attendance, voting results on various proposals including amendments to the articles of association and board nominations, and includes legal witness statements confirming the validity of the meeting and votes. There is no financial data or report content, but rather official voting results and meeting procedural information. This matches the definition of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is short and focused on voting outcomes, not a full report or presentation.
2017-10-25 Chinese
重大资产重组进展公告
Capital/Financing Update Classification · 95% confidence The document is titled as a "重大资产重组进展公告" which translates to "Major Asset Restructuring Progress Announcement." It discusses the ongoing process of a major asset restructuring involving a subsidiary and mentions stock suspension due to this matter. The document is relatively short (801 characters) and focuses on announcing the progress and procedural updates rather than providing detailed financial data or a full report. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes such as major asset restructurings.
2017-10-25 Chinese
关于选举职工监事的公告
Board/Management Information Classification · 95% confidence The document is a short announcement regarding the election of an employee supervisor (职工监事) at 哈药集团股份有限公司. It includes a statement of responsibility from the supervisory board and a brief resume of the elected individual. There is no financial data, no mention of financial results, no regulatory filings, no voting results from a general meeting, and no indication of a report being attached or published. The content is about a board/management related personnel announcement, specifically about the election of a supervisory board member. Therefore, the most appropriate classification is Board/Management Information (MANG). The document length is short and focused on management personnel changes, fitting the MANG category with high confidence.
2017-10-25 Chinese
重大资产重组停牌前股东持股情况公告
Major Shareholding Notification Classification · 95% confidence The document is titled as an announcement regarding the shareholder holdings before a trading suspension due to a major asset restructuring. It lists the top ten shareholders and their shareholdings, referencing a prior suspension announcement. The content is focused on shareholder information related to a capital restructuring event, not a full financial report or earnings release. It is not a report publication announcement since it contains substantive shareholder data. The document fits best as a Major Shareholding Notification (MRQ) because it discloses significant share ownership details in the context of a major asset restructuring and trading suspension.
2017-10-19 Chinese
重大资产重组停牌公告
Capital/Financing Update Classification · 95% confidence The document is a formal announcement from 哈药集团股份有限公司 regarding a major asset restructuring (重大资产重组) and the consequent trading suspension (停牌公告). It discusses the ongoing planning of a significant asset purchase, the uncertainty involved, and the temporary suspension of stock trading to ensure fair disclosure and protect investors. The document references regulatory compliance and the involvement of auditing, legal, and financial advisory institutions. It does not contain financial statements or detailed financial data but is an announcement about the status and procedural steps of a major corporate action. Therefore, it fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes such as major asset restructurings.
2017-10-18 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.